Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 25:13:921003.
doi: 10.3389/fphar.2022.921003. eCollection 2022.

Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials

Affiliations
Review

Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials

Shenglei Yang et al. Front Pharmacol. .

Abstract

Osteoarthritis (OA) is one of the progressing chronic joint associated with by many complex factors such as age, obesity, and trauma. Knee osteoarthritis (KOA) is the most common type of OA. KOA is characterized by articular cartilage destruction and degeneration, synovial inflammation, and abnormal subchondral bone changes. To date, no practical clinical approach has been able to modify the pathological progression of KOA. Drug therapy is limited to pain control and may lead to serious side effects when taken for a long time. Therefore, searching for safer and more reliable treatments has become necessary. Interestingly, more and more research has focused on natural products, and monomeric compounds derived from natural products have received much attention as drug candidates for KOA treatment. Resveratrol (RES), a natural phenolic compound, has various pharmacological and biological activities, including anti-cancer, anti-apoptotic, and anti-decay. Recently, studies on the effects of RES on maintaining the normal homeostasis of chondrocytes in KOA have received increasing attention, which seems to be attributed to the multi-targeted effects of RES on chondrocyte function. This review summarizes preclinical trials, clinical trials, and emerging tissue engineering studies of RES for KOA and discusses the specific mechanisms by which RES alleviates KOA. A better understanding of the pharmacological role of RES in KOA could provide clinical implications for intervention in the development of KOA.

Keywords: apoptosis; chondrocytes; inflammation; knee; osteoarthritis; resveratrol; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Resveratrol chemical structures (trans and cis forms) and its biological activities and toxic side effects. (A) Trans-resveratrol. (B) Cis-resveratrol. (C) Biological activities and toxic side effects of resveratrol.
FIGURE 2
FIGURE 2
Potential mechanisms of resveratrol in relieving knee osteoarthritis. There are many molecular mechanisms involved in the occurrence and development of knee osteoarthritis. Resveratrol plays multiple positive roles in knee osteoarthritis, reducing inflammatory activation, cell apoptosis, maintaining cartilage homeostasis and promoting autophagy through several signal pathways. (A) Anti-inflammatory effects. (B) Anti-apoptotic/proliferous effects. (C) Anti-catabolic/Pro-anabolic effects. (D) Autophagy-promoting effects. ↑: up-regulation. ↓: down-regulation.
FIGURE 3
FIGURE 3
The new application of resveratrol in knee osteoarthritis. The schematic diagram illustrates the current clinical method of combining resveratrol with cartilage tissue engineering to treat knee osteoarthritis.

Similar articles

Cited by

References

    1. Abdali D., Samson S. E., Grover A. K. (2015). How Effective Are Antioxidant Supplements in Obesity and Diabetes? Med. Princ. Pract. 24 (3), 201–215. 10.1159/000375305 - DOI - PMC - PubMed
    1. Andrade S., Ramalho M. J., Pereira M. D. C., Loureiro J. A. (2018). Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment. Front. Pharmacol. 9, 1261. 10.3389/fphar.2018.01261 - DOI - PMC - PubMed
    1. Anekonda T. S. (2006). Resveratrol--a Boon for Treating Alzheimer's Disease? Brain Res. Rev. 52 (2), 316–326. 10.1016/j.brainresrev.2006.04.004 - DOI - PubMed
    1. Ansari M. Y., Ahmad N., Haqqi T. M. (2020). Oxidative Stress and Inflammation in Osteoarthritis Pathogenesis: Role of Polyphenols. Biomed. Pharmacother. 129, 110452. 10.1016/j.biopha.2020.110452 - DOI - PMC - PubMed
    1. Asensi M., Medina I., Ortega A., Carretero J., Baño M. C., Obrador E., et al. (2002). Inhibition of Cancer Growth by Resveratrol Is Related to its Low Bioavailability. Free Radic. Biol. Med. 33 (3), 387–398. 10.1016/s0891-5849(02)00911-5 - DOI - PubMed

LinkOut - more resources